Yingjie Zhang
+
Gender:Male
Education Level:Postgraduate (Doctoral)
Alma Mater:山东大学
Paper Publications
- [61] Yingjie Zhang and xuwenfang. Synthesis of chiral ND-322, ND-364 and ND-364 derivatives as selective inhibitors of human gelatinase. Bioorg. Med. Chem., 2015.
- [62] Yingjie Zhang. Development of N-hydroxybenzamide derivatives with indole containing cap group as histone deacetylases inhibitors. Bioorg. Med. Chem., 2015.
- [63] Yingjie Zhang and xuwenfang. Enhanced anticancer activity of 5-FU in combination with Bestatin: Evidence in human tumor-derived cell lines and an H22 tumor-bearing mouse. Drug Discov. Ther., 2015.
- [64] Yingjie Zhang and xuwenfang. Isoform-selective histone deacetylase inhibitors: the trend and promise of disease treatment. Epigenomics, 2015.
- [65] Yingjie Zhang and xuwenfang. Design, Synthesis, and Antitumor Evaluation of 4？Amino-2 (1H)？pyrazole Derivatives as JAKs Inhibitors. ACS Med. Chem. Lett., 2016.
- [66] Yingjie Zhang and xuwenfang. VEGF signal system: the application of antiangiogenesis.. Curr. Med. Chem., 2014.
- [67] Yingjie Zhang and xuwenfang. Discovery of N-(3-((7H-purin-6-yl)thio)-4-hydroxynaphthalen-1-yl) -sulfonamide derivatives as novel protein kinase and angiogenesis inhibitors for the treatment of cancer: Synthesis and biological evaluation. Part III.. Bioorg. Med. Chem., 2014.
- [68] Yingjie Zhang and xuwenfang. Design and synthesis of a tetrahydroisoquinoline-based hydroxamate derivative (ZYJ-34v), an oral active histone deacetylase inhibitor with potent antitumor activity. Chem. Biol. Drug Des, 2013.
- [69] Yingjie Zhang and xuwenfang. Development of N-Hydroxycinnamamide-Based Histone Deacetylase Inhibitors with an Indole-Containing Cap Group. ACS Med. Chem. Lett., 2013.
- [70] Yingjie Zhang. Developments of Polo-like Kinase 1 (Plk1) Inhibitors as Anti-Cancer Agents. Mini. Rev. Med. Chem., 13, 2014, 2013.